Insider · CIK 0001023260
Arthur F Golden
Files at TTRX (Turn Therapeutics Inc.). First filing Oct 23, 2025, latest Nov 25, 2025.
In brief
Arthur F Golden files SEC Form 4 as director at TTRX (Turn Therapeutics Inc.). Since Oct 23, 2025, Arthur F Golden has reported 3 open-market buys worth $193k and 0 open-market sells worth $0, the latest filed on Nov 25, 2025.
A track record needs three past buys with six months of prices behind them; Arthur F Golden has 0, so none is measured yet.
The newest scored trade: bought $34k of TTRX on Nov 24, 2025, filed Nov 25, 2025, scored 37 (weak). In the last 12 months: 3 buys worth $193k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TTRX: Turn Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Turn Therapeutics Inc. | $34k 9,868 shares | +19% | - | |
| 45Moderate | Turn Therapeutics Inc. | $59k 20,532 shares | +68% | - | |
| 50Moderate | Turn Therapeutics Inc. | $100k 20,202 shares | +202% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | TTRX Turn Therapeutics Inc. | AGrant or award Stock option (right to buy)derivative | +89,584 | $0.00 | $0 | 89,584 | Jun 8, 2026 |
| Apr 2, 2026 | TTRX Turn Therapeutics Inc. | GGift Common Stock | +300,000 | $0.00 | $0 | 360,602 | Apr 3, 2026 |
| Nov 24, 2025 | TTRX Turn Therapeutics Inc. | POpen-market purchase Common Stock | +9,868 | $3.44 | $34k | 60,602 | Nov 25, 2025 |
| Nov 21, 2025 | TTRX Turn Therapeutics Inc. | POpen-market purchase Common Stock | +20,532 | $2.87 | $59k | 50,734 | Nov 24, 2025 |
| Oct 23, 2025 | TTRX Turn Therapeutics Inc. | POpen-market purchase Common Stock | +20,202 | $4.95 | $100k | 30,202 | Oct 23, 2025 |
| Oct 8, 2025 | TTRX Turn Therapeutics Inc. | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 10,000 | Oct 10, 2025 |
Questions about Arthur F Golden
Answered from the filings on this page, as of the latest one.
Is Arthur F Golden buying or selling?
In the last 12 months Arthur F Golden reported 3 open-market buys worth $193k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $34k of TTRX on Nov 24, 2025. Grants, option exercises and tax withholding are not counted.
How did Arthur F Golden's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Arthur F Golden has 0.
Where does Arthur F Golden file Form 4?
Arthur F Golden has filed Form 4 at TTRX (Turn Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.